Ron Cohen Acorda Therapeutics Inc (ACOR) insider trading activity

ACOR Quotes by TradingView

Ron Cohen is President and CEO of ACORDA THERAPEUTICS INC. Currently has a direct ownership of 149,757 shares of ACOR, which is worth approximately $38,936. The most recent transaction as insider was on Mar 17, 2023, when has been sold 10,000 shares (Common Stock) at a price of $0.65 per share, resulting in proceeds of $6,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 150K
0% 3M change
0% 12M change
Total Value Held $38,936

RON COHEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2023
BUY
Open market or private purchase
$6,500 $0.65 p/Share
10,000 Added 6.26%
149,757 Common Stock
Mar 16 2023
BUY
Open market or private purchase
$6,093 $0.6 p/Share
10,156 Added 6.77%
139,757 Common Stock
Mar 17 2022
SELL
Open market or private sale
$3,891 $1.7 p/Share
2,289 Reduced 1.74%
129,601 Common Stock
Sep 03 2021
SELL
Payment of exercise price or tax liability
$17,257 $4.38 p/Share
3,940 Reduced 2.9%
131,890 Common Stock
Mar 03 2021
BUY
Grant, award, or other acquisition
-
29,000 Added 17.59%
135,830 Common Stock
RC

Ron Cohen

President and CEO
Ardsley, NY

Track Institutional and Insider Activities on ACOR

Follow ACORDA THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACOR shares.

Notify only if

Insider Trading

Get notified when an Acorda Therapeutics Inc insider buys or sells ACOR shares.

Notify only if

News

Receive news related to ACORDA THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACOR